CCJ Form 144: 500 Common Shares Proposed Sale via BMO Investorline on NYSE

Rhea-AI Filing Summary

Cameco Corporation (CCJ) submitted a Form 144 reporting a proposed sale of 500 common shares with an aggregate market value of 36,170.00, to be sold approximately on 06/24/2025 on the NYSE through BMO Investorline.

The filing shows those shares were acquired by open-market purchases on 11/04/2014 (400 shares) and 11/06/2014 (100 shares), paid in cash. It lists total shares outstanding of 435,387,448 and records a sale of 500 shares on 06/23/2025 with gross proceeds of 34,860.00. The seller certifies they are unaware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Form 144 notifies a small, likely immaterial sale of 500 CCJ shares versus 435.4M outstanding, so market impact is minimal.

The notice documents a proposed sale of 500 common shares valued at 36,170.00, to be executed via BMO Investorline on the NYSE around 06/24/2025. Relative to the 435,387,448 shares outstanding, the size is de minimis and unlikely to affect liquidity or share price. The filing follows standard disclosure practice for restricted or control-holder sales and includes prior acquisition dates in 2014, indicating long-term holding before the sale.

Corporate Governance Expert

TL;DR: Disclosure appears routine; seller affirms no undisclosed adverse information, so governance implications are limited.

The form includes the required representation that the seller does not possess material nonpublic adverse information, and it documents acquisition method (open-market purchases in 2014) and payment in cash. The presence of a near-term executed sale on 06/23/2025 with proceeds reported suggests compliance with reporting obligations. There are no indications of insider trading plans referenced or governance concerns disclosed within this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	BMO Investorline 100 King St W Floor B1 Toronto A6 M5X 1H3	500	36170.00	435387448	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	11/04/2014	Open Market Purchase	Open Market Purchase			400	11/04/2014	Cash
Common Shares	11/06/2014	Open Market Purchase	Open Market Purchase			100	11/06/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Catherine Gignac 2121 11th Street West Saskatoon A9 S7M 1J3	Common Shares	06/23/2025	500	34860.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities is Cameco (CCJ) proposing to sell in this Form 144?

The filing proposes the sale of 500 common shares with an aggregate market value of 36,170.00, to be sold approximately on 06/24/2025 on the NYSE.

Who is listed as a recent seller related to this Form 144 for CCJ?

The filings list Catherine Gignac as a seller who sold 500 common shares on 06/23/2025 for gross proceeds of 34,860.00.

How and when were the shares being sold originally acquired?

The shares were acquired via open-market purchases, specifically 400 shares on 11/04/2014 and 100 shares on 11/06/2014, paid in cash.

Through which broker and exchange will the CCJ shares be sold?

The broker listed is BMO Investorline (100 King St W, Toronto) and the intended exchange is the NYSE.

How many CCJ shares are outstanding according to this filing?

The filing lists 435,387,448 shares outstanding.

Does the seller make any certification about material information?

Yes, the person for whose account the securities are to be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.